In another Swedish regional register, the incidence rate of the first cardiovascular disease event was lower in anti-TNF-treated patients (14.0/1000 person-years) than in those who were not treated (35.4/1000 person-years) (62). The gene discussed is TNF; the disease is cardiovascular disorder.